On 1 November 2020 cost recovery arrangements for the Medicinal Cannabis Scheme in the Narcotic Drugs Act 1967 will change to introduce fees and charges for cannabis-related manufacture licences and permits granted under the Scheme.
The Office of Drug Control (ODC) is seeking comments from interested parties on the proposed Medicinal Cannabis Cost Recovery Framework. Closing date: 20 March 2020
The Australian Government will boost the nation's medicinal cannabis industry by prioritising projects that have been granted Major Project Status (MPS) and ultimately driving economic growth.
